PASGPassage Bio, Inc.

PASG Stock Price, Valuation & Chart | Passage Bio, Inc.

Compare

$4.610+0.17 (+3.83%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology PASG intrinsic value PASG calculated fair value vs price

Overview Financials Dividends Ratios

PASG Historical price chart

PASG Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization14.81M

PE Ratio-0.39

EPS-11.84

Trading Volume3.44K

Today's High/Low4.65/4.45

Dividend Yield0.00

52 Week High/Low20.0/3.29

Shares Outstanding3.21M

PASG Financial Statement

PASG Analyst ratings

PASG Analysis & performance metrics

PASG Company profile

Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary,…

Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a…

PASG Management team

Name

Position

Kathleen BorthwickCFO

Senior Vice President, Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

William Chou M.D.CEO

President, Chief Executive Officer & Director

Sue Browne Ph.D.

Chief Scientific Officer

Eden Fucci

Senior Vice President of Technical Operations

Stuart M. Henderson

Chief Business Officer

Karl Whitney Ph.D.

Senior Vice President of Global Regulatory Affairs

Edgar B. Cale Esq., J.D.

General Counsel & Company Secretary

Name

Position

Kathleen BorthwickCFO

Senior Vice President, Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

William Chou M.D.CEO

President, Chief Executive Officer & Director

Sue Browne Ph.D.

Chief Scientific Officer

Eden Fucci

Senior Vice President of Technical Operations

Stuart M. Henderson

Chief Business Officer

Karl Whitney Ph.D.

Senior Vice President of Global Regulatory Affairs

Edgar B. Cale Esq., J.D.

General Counsel & Company Secretary

Management Team

Kathleen BorthwickCFO

Senior Vice President, Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

William Chou M.D.CEO

President, Chief Executive Officer & Director

Sue Browne Ph.D.

Chief Scientific Officer

Eden Fucci

Senior Vice President of Technical Operations

Stuart M. Henderson

Chief Business Officer

Karl Whitney Ph.D.

Senior Vice President of Global Regulatory Affairs

Edgar B. Cale Esq., J.D.

General Counsel & Company Secretary

Management

Kathleen BorthwickCFO

Senior Vice President, Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

William Chou M.D.CEO

President, Chief Executive Officer & Director

Sue Browne Ph.D.

Chief Scientific Officer

Eden Fucci

Senior Vice President of Technical Operations

Stuart M. Henderson

Chief Business Officer

Karl Whitney Ph.D.

Senior Vice President of Global Regulatory Affairs

Edgar B. Cale Esq., J.D.

General Counsel & Company Secretary

Total 7 executives

PASG Frequently asked questions

What is Passage Bio, Inc. (PASG) Stock Price?

Current stock price of Passage Bio, Inc. (PASG) stock is $4.610. The stock price is +3.83% higher in the session. The intraday range can be seen from this page. Volume of Passage Bio, Inc. (PASG) stock is 3.44K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Passage Bio, Inc. (PASG) stock price going up or down today?

The stock price of Passage Bio, Inc. (PASG) can change with earnings, company news, and overall market sentiment. Passage Bio, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Passage Bio, Inc. stock expensive at its current price?

Whether Passage Bio, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PASG on this page is -0.39. EPS on this page is -11.84. Compare those figures with peers and growth expectations before deciding if the current Passage Bio, Inc. price is justified.

How has the stock price of Passage Bio, Inc. (PASG) performed historically?

Historical performance for Passage Bio, Inc. (PASG) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PASG reacted to past earnings and market events.

Should I buy Passage Bio, Inc. (PASG) stock, at this price?

Buying Passage Bio, Inc. (PASG) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.